178 related articles for article (PubMed ID: 20938929)
1. Tetraspanins in human epithelial malignancies.
Romanska HM; Berditchevski F
J Pathol; 2011 Jan; 223(1):4-14. PubMed ID: 20938929
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal tumors: metastasis and tetraspanins.
Zöller M
Z Gastroenterol; 2006 Jul; 44(7):573-86. PubMed ID: 16823699
[TBL] [Abstract][Full Text] [Related]
3. Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells.
Sauer G; Kurzeder C; Grundmann R; Kreienberg R; Zeillinger R; Deissler H
Oncol Rep; 2003; 10(2):405-10. PubMed ID: 12579280
[TBL] [Abstract][Full Text] [Related]
4. Trafficking and function of the tetraspanin CD63.
Pols MS; Klumperman J
Exp Cell Res; 2009 May; 315(9):1584-92. PubMed ID: 18930046
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
6. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
Zhou B; Liu L; Reddivari M; Zhang XA
Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
[TBL] [Abstract][Full Text] [Related]
7. Tetraspanin CD82 controls the association of cholesterol-dependent microdomains with the actin cytoskeleton in T lymphocytes: relevance to co-stimulation.
Delaguillaumie A; Harriague J; Kohanna S; Bismuth G; Rubinstein E; Seigneuret M; Conjeaud H
J Cell Sci; 2004 Oct; 117(Pt 22):5269-82. PubMed ID: 15454569
[TBL] [Abstract][Full Text] [Related]
8. Membrane microdomains and proteomics: lessons from tetraspanin microdomains and comparison with lipid rafts.
Le Naour F; André M; Boucheix C; Rubinstein E
Proteomics; 2006 Dec; 6(24):6447-54. PubMed ID: 17109380
[TBL] [Abstract][Full Text] [Related]
9. A physical and functional link between cholesterol and tetraspanins.
Charrin S; Manié S; Thiele C; Billard M; Gerlier D; Boucheix C; Rubinstein E
Eur J Immunol; 2003 Sep; 33(9):2479-89. PubMed ID: 12938224
[TBL] [Abstract][Full Text] [Related]
10. Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer.
Ow K; Delprado W; Fisher R; Barrett J; Yu Y; Jackson P; Russell PJ
J Pathol; 2000 May; 191(1):39-47. PubMed ID: 10767717
[TBL] [Abstract][Full Text] [Related]
11. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
[TBL] [Abstract][Full Text] [Related]
12. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
[TBL] [Abstract][Full Text] [Related]
13. Functional implications of tetraspanin proteins in cancer biology.
Lazo PA
Cancer Sci; 2007 Nov; 98(11):1666-77. PubMed ID: 17727684
[TBL] [Abstract][Full Text] [Related]
14. Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues.
Turtoi A; Dumont B; Greffe Y; Blomme A; Mazzucchelli G; Delvenne P; Mutijima EN; Lifrange E; De Pauw E; Castronovo V
J Proteome Res; 2011 Jul; 10(7):3160-82. PubMed ID: 21534635
[TBL] [Abstract][Full Text] [Related]
15. Loss of KAI1 expression in the progression of colorectal cancer.
Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
[TBL] [Abstract][Full Text] [Related]
16. The tetraspanin D6.1A and its molecular partners on rat carcinoma cells.
Claas C; Wahl J; Orlicky DJ; Karaduman H; Schnölzer M; Kempf T; Zöller M
Biochem J; 2005 Jul; 389(Pt 1):99-110. PubMed ID: 15725074
[TBL] [Abstract][Full Text] [Related]
17. Native type IV collagen induces cell migration through a CD9 and DDR1-dependent pathway in MDA-MB-231 breast cancer cells.
Castro-Sanchez L; Soto-Guzman A; Navarro-Tito N; Martinez-Orozco R; Salazar EP
Eur J Cell Biol; 2010 Nov; 89(11):843-52. PubMed ID: 20709424
[TBL] [Abstract][Full Text] [Related]
18. KAI1 tetraspanin and metastasis suppressor.
Jackson P; Marreiros A; Russell PJ
Int J Biochem Cell Biol; 2005 Mar; 37(3):530-4. PubMed ID: 15618009
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival.
Gong YP; Yarrow PM; Carmalt HL; Kwun SY; Kennedy CW; Lin BP; Xing PX; Gillett DJ
Eur J Surg Oncol; 2007 May; 33(4):438-43. PubMed ID: 17125961
[TBL] [Abstract][Full Text] [Related]
20. Interaction of CD82 tetraspanin proteins with HTLV-1 envelope glycoproteins inhibits cell-to-cell fusion and virus transmission.
Pique C; Lagaudrière-Gesbert C; Delamarre L; Rosenberg AR; Conjeaud H; Dokhélar MC
Virology; 2000 Oct; 276(2):455-65. PubMed ID: 11040136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
